ロード中...
Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer
OBJECTIVES: Gonadotropin-releasing hormone agonists are widely used as androgen deprivation therapy in many men with locally advanced or metastatic prostate cancer. Gonadotropin-releasing hormone agonists are delivered by intramuscular injection every 1, 3 or 6 months, but in some patients subcutane...
保存先:
| 出版年: | Ther Adv Urol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485417/ https://ncbi.nlm.nih.gov/pubmed/26161143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215577329 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|